Company intelligence / Profile preview
2seventy bio
Cambridge, Massachusetts, United States2seventybio.com ↗
- Ownership
- Public · TSVT
- Employees
- ~65
- Development stage
- Commercial
01
Overview
Abecma® (idecabtagene vicleucel), a BCMA-directed CAR-T cell therapy co-developed with Bristol Myers Squibb for relapsed/refractory multiple myeloma, has achieved commercial status. In early 2024 the company sold its remaining R&D pipeline to Regeneron to focus exclusively on maximizing the potential of Abecma. The company’s streamlined team now supports commercialization and access efforts for this product.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapy (CAR-T)Gene therapy (historically; now focused on cell therapy)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Bristol Myers Squibb (co-development/commercialization partner for Abecma)Regeneron (previously partnered on pipeline assets; acquired R&D portfolio in early/mid–2024)Novo Nordisk and JW Therapeutics were also mentioned as partners during earlier stages before strategic refocus.
Beyond the preview
Go deeper on 2seventy bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2seventy bio.